Aspira Net Income From Continuing Ops from 2010 to 2025

AWH Stock  USD 0.17  0.06  26.09%   
Aspira Womens' Net Loss is decreasing with slightly volatile movements from year to year. Net Loss is estimated to finish at about -13.2 M this year. For the period between 2010 and 2025, Aspira Womens, Net Loss quarterly trend regression had mean deviation of  214,095,669 and range of 522 M. View All Fundamentals
 
Net Loss  
First Reported
2016-06-30
Previous Quarter
-3.5 M
Current Value
-3.5 M
Quarterly Volatility
38.1 M
 
Covid
Check Aspira Womens financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aspira Womens' main balance sheet or income statement drivers, such as Depreciation And Amortization of 170.1 K, Interest Expense of 14.5 K or Selling General Administrative of 11.5 M, as well as many indicators such as Price To Sales Ratio of 4.5, Dividend Yield of 0.0094 or Days Sales Outstanding of 73.06. Aspira financial statements analysis is a perfect complement when working with Aspira Womens Valuation or Volatility modules.
  
Check out the analysis of Aspira Womens Correlation against competitors.

Latest Aspira Womens' Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Aspira Womens Health over the last few years. It is Aspira Womens' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aspira Womens' overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Aspira Net Income From Continuing Ops Regression Statistics

Arithmetic Mean147,746,929
Geometric Mean51,983,661
Coefficient Of Variation162.36
Mean Deviation214,095,669
Median(11,371,000)
Standard Deviation239,876,194
Sample Variance57540.6T
Range522M
R-Value(0.83)
Mean Square Error19010.8T
R-Squared0.69
Significance0.000065
Slope(41,901,751)
Total Sum of Squares863108.8T

Aspira Net Income From Continuing Ops History

2025-13.2 M
2024-13.9 M
2023-15.5 M
2022-27.2 M
2021-31.7 M
2020-17.9 M
2019-15.2 M

About Aspira Womens Financial Statements

Investors use fundamental indicators, such as Aspira Womens' Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Aspira Womens' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Loss-13.9 M-13.2 M

Currently Active Assets on Macroaxis

When determining whether Aspira Womens Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aspira Womens' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aspira Womens Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aspira Womens Health Stock:
Check out the analysis of Aspira Womens Correlation against competitors.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.15)
Revenue Per Share
0.714
Quarterly Revenue Growth
0.018
Return On Assets
(1.58)
Return On Equity
(7.23)
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.